Seres Therapeutics shares owned by T. Rowe Price Associates
Quarter-by-quarter ownership of Seres Therapeutics (MCRB) shares owned by T. Rowe Price Associates
from 13F filings
Historical chart of T. Rowe Price Associates investment in Seres Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Seres Therapeutics held by T. Rowe Price Associates consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Seres Therapeutics by T. Rowe Price Associates
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2023-12-31 | $510k | 364k | 1.40 |
| 2023-09-30 | $791k | 332k | 2.38 |
| 2023-06-30 | $1.5M | 314k | 4.79 |
| 2023-03-31 | $3.3M | 584k | 5.67 |
| 2022-12-31 | $3.3M | 583k | 5.60 |
| 2022-03-31 | $4.0M | 568k | 7.12 |
| 2021-12-31 | $4.7M | 561k | 8.33 |
| 2021-09-30 | $9.5M | 1.4M | 6.96 |
| 2021-06-30 | $33M | 1.4M | 23.85 |
| 2021-03-31 | $29M | 1.4M | 20.59 |
| 2020-12-31 | $46M | 1.9M | 24.50 |
| 2020-09-30 | $17M | 582k | 28.31 |
| 2020-06-30 | $125k | 26k | 4.77 |
| 2020-03-31 | $194k | 54k | 3.58 |
| 2019-12-31 | $186k | 54k | 3.45 |
| 2019-09-30 | $210k | 52k | 4.01 |
| 2019-06-30 | $167k | 52k | 3.21 |
| 2019-03-31 | $621k | 90k | 6.87 |
| 2018-12-31 | $467k | 103k | 4.52 |
| 2018-09-30 | $784k | 103k | 7.59 |
| 2018-06-30 | $887k | 103k | 8.60 |
| 2018-03-31 | $757k | 103k | 7.34 |
| 2017-12-31 | $1.0M | 103k | 10.14 |
| 2017-06-30 | $5.2M | 464k | 11.30 |
| 2017-03-31 | $8.1M | 717k | 11.27 |
| 2016-12-31 | $7.4M | 752k | 9.90 |
| 2016-09-30 | $9.3M | 754k | 12.29 |
| 2016-06-30 | $33M | 1.1M | 29.05 |
| 2016-03-31 | $25M | 951k | 26.56 |
| 2015-12-31 | $34M | 962k | 35.09 |
| 2015-09-30 | $28M | 959k | 29.00 |